Search

everythinglearnresearchcommunity

for

Search:↓

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Topical melatonin is a safe treatment that may reduce hair loss in people with androgenetic alopecia.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Testosterone may slow down wound healing and increase inflammation.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Topical nitroglycerin spray effectively prevents scalp necrosis in hair transplant patients.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Proper planning for hair transplants is crucial for natural results, with careful patient selection and strategic graft placement being key factors.

Immune activities and specific genes are important in male pattern baldness.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

A 4-year-old girl with hair loss was diagnosed with early-onset trichotillomania and improved with behavioral interventions.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Early balding men may have insulin resistance, but lifestyle changes can help.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.